Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001232524-17-000185
Filing Date
2017-12-13
Accepted
2017-12-13 17:52:40
Documents
1
Period of Report
2017-12-11

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 15688
  Complete submission text file 0001232524-17-000185.txt   17221
Mailing Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4
Business Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4 353-1-634-7800
Jazz Pharmaceuticals plc (Issuer) CIK: 0001232524 (see all company filings)

EIN.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address CO LONGITUDE CAPITAL PARTNERS LLC 800 EL CAMINO REAL, SUITE 220 MENLO PARK CA 94025
Business Address
ENRIGHT PATRICK G (Reporting) CIK: 0001253886 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33500 | Film No.: 171254740